Miss Laysla V Pouzo Amorim, Brazil
Higher immunogenicity of a third heterologous dose with BNT262b2 mRNA vaccine compared to a homologous dose in kidney transplant recipients fully vaccinated with inactivated whole-virion CoronaVac vaccine
Dr. Susana K Villamil Cortez, Argentina
Safety and Immunogenicity protocol of vaccination for SARS-COV 2 in solid organ transplant patients in Argentina-Sociedad Argentina de Trasplante
Dr. Jennifer L. Alejo, United States
A prediction model for antibody response to three vaccines against SARS-CoV-2 among solid organ transplant recipients
Dr. Camilo E Ulloa, Chile
Multicenter study to determine the immune response to the vaccine against SARS COV-2, in patients with chronic kidney disease on dialysis and kidney transplants